Perimenopause in Two Languages: Kidney Decline and the Hormone Curve
The first time a patient describes perimenopause to me, I usually hear some version of the same sentence: I feel like my body stopped being predictable and nobody can tell me why.
Then she tells me her labs came back normal, which they often do, because a single hormone measurement during a phase defined by erratic hormones is one frame from a film.
This is a place where two frameworks describe the same transition with unusual precision, and where each catches something the other misses.
What is actually happening, biologically
Perimenopause is not a slow, steady decline. That is the most persistent misconception about it, and it is why the standard workup so often comes back unremarkable.
Ovarian follicle supply diminishes with age. As it does, the pituitary compensates by increasing FSH, which can drive cycles where estrogen surges higher than in a person's twenties. What follows is not a smooth downward slope but a period of increasing volatility: some cycles anovulatory, some with heavy estrogen output, progesterone declining earlier and more consistently than estrogen does.
That progesterone-to-estrogen relationship is where most of the symptom burden originates. Progesterone is calming and sleep-supporting through its effect on GABA receptors. When it drops while estrogen remains variable, the result is anxiety that arrives without cause, sleep that fragments around 3 a.m., heavier or closer-together periods, and an emotional volatility that patients often describe as feeling unlike themselves.
Two other systems are dragged into it. Estrogen influences thyroid binding globulin, so thyroid symptoms frequently surface or worsen during this window. Cortisol and sex hormones share upstream resources and regulatory pathways, so a person under sustained stress goes through this transition harder than someone who is not.
Why one blood draw often misses it. A day-3 FSH or a mid-luteal progesterone captures one point in a system whose defining feature is that it no longer behaves the same way twice. A normal result rules out very little.
What Chinese medicine saw without measuring anything
Classical Chinese medicine described this transition in detail centuries before anyone could measure a hormone, because it was observing the pattern rather than the mechanism.
The framework is Kidney decline — the gradual spending of Jing, the constitutional reserve that governs reproduction, bone, and the arc of aging. What matters clinically is which aspect is depleted, because the treatment diverges sharply.
Kidney yin deficiency is the pattern people usually picture. Hot flashes, night sweats, waking heat, dryness — of skin, eyes, vagina — insomnia in the second half of the night, irritability, a red tongue with little coating, and a thin rapid pulse. The cooling, moistening, anchoring aspect has been depleted, and heat rises unopposed. Treatment nourishes yin and clears the deficient heat.
Kidney yang deficiency is the pattern that gets missed, because it does not match the cultural script. Cold hands and feet, low back ache, fatigue that sleep does not touch, weight gain, low mood, frequent pale urination, loose stools. No hot flashes at all. These patients are often told they are not really in perimenopause. Treatment warms and tonifies — and giving this person the cooling formula built for the yin pattern makes her considerably worse.
Liver qi stagnation overlays both. Irritability, breast tenderness, premenstrual worsening, tension under the ribs, sighing, digestive symptoms that track with stress. This is the pattern that responds fastest to treatment and produces the quickest relief.
Heart-Kidney disharmony describes the specific insomnia of this transition: falling asleep without difficulty, then waking at 3 a.m. with heat and a racing mind. The anchoring relationship between the two systems has failed.
Where they meet
The correspondences here are tighter than in most of the two systems, and they are still analogies rather than equivalences.
Kidney yin deficiency and estrogen decline with vasomotor instability describe overlapping clinical pictures. Heat, dryness, night waking, thinning tissue.
Kidney yang deficiency and the thyroid-plus-cortisol presentation overlap in a way that is clinically useful. Cold, fatigue, weight gain, low mood. When I see a yang-deficient perimenopausal pattern, a full thyroid panel — free T3 and antibodies, not TSH alone — is warranted more often than not.
Liver qi stagnation and the progesterone-to-estrogen shift track together closely. The premenstrual worsening, the irritability, the breast tenderness.
What does not translate: Jing is not a measurable quantity. There is no assay for constitutional reserve. Anyone offering one is selling something.
What running both actually changes
Pattern differentiation decides the pace and the direction. The yin-deficient patient and the yang-deficient patient have the same diagnosis and need opposite interventions. Warming herbs help one and worsen the other. No hormone panel makes that distinction, because it is not a question about hormone levels — it is a question about what state the person is in.
Labs catch what the pattern cannot name. Thyroid antibodies, ferritin, fasting insulin, vitamin D, a lipid panel. Perimenopause is also the window where cardiovascular and bone risk shift meaningfully, and those changes are silent. Pattern assessment will not find them. A blood draw will.
The pattern moves before the labs do. Sleep improves, hot flashes reduce in frequency, the pulse changes quality — and a repeat panel three months later looks about the same. That is not failure. Physiology moves faster than the markers used to measure it.
Acupuncture has reasonable evidence here. Trials on vasomotor symptoms are mixed in quality and effect size, and I would not overstate them. The consistent signal is on sleep and on the frequency and intensity of hot flashes rather than their elimination. That is a modest claim, and it is the accurate one.
None of this replaces hormone therapy. Hormone therapy is a legitimate, evidence-supported option, and that decision belongs to a prescriber. Some patients do both. Some cannot take it and need everything else to work harder. A practitioner who positions integrative care as the natural alternative to a medication you may genuinely need is not looking out for you.
What this means for you
If you are being told your labs are normal and your body clearly disagrees, that is expected in this transition rather than evidence that nothing is happening.
If you are cold, exhausted, and gaining weight with no hot flashes, you may still be squarely in perimenopause — and you should be assessed for the yang-deficient pattern and for thyroid involvement, both of which get missed when hot flashes are treated as the entry requirement.
If a treatment made you feel worse, that is real information. It usually means the plan was built for the opposite pattern.
Somewhere in this transition and not getting clear answers? Text us at (206) 402-3813 and describe what has already been checked.
Courtney M. Zeller, AEMP, L.Ac., MS is the owner and primary practitioner at GoodMedizen in downtown Seattle.
This article is educational and is not medical advice. Decisions about hormone therapy belong with your prescribing provider. Nothing here is intended to diagnose, treat, cure, or prevent any disease.
.png)

Comments